From the WHO website; this is a pdf but I have cut & pasted a few relevant extracts. The document in total is only 15 pages long, but enlightening in the sense that the PNAC document was 'enlightening' as well:
Comment: this last comment was news to me; in following the progression of this story there appeared to be strong circumstancial evidence that the Spanish flu of 1918 was either propogated by, or accelerated by, the initial use of vaccinations on soldiers (and civilians).World Health Association said:[...]
To date, H5N1 viruses have not been associated with the type of community-wide
outbreaks that are characteristic of human influenza. However, all influenza viruses have
the capacity to undergo genetic and antigenic change in unpredictable ways. Concern is
great that such change could allow the H5N1 virus to spread efficiently and sustainably
among people. Should an H5N1 virus anywhere in the world develop this ability, and if
the outbreak caused by its initial emergence is not contained, the chances are very high
that the virus will spread globally and cause a pandemic. The 1918 pandemic virus,
which is thought to have originated as a purely avian influenza virus, resulted in an
estimated 40 to 50 million deaths worldwide within one year.
The following extract may give us some indication as to when this might occur:WHO said:[...]
If a decision to initiate containment is made, WHO will become the coordinating body for
all international support. WHO and its global partners will work with the country to
mobilize necessary resources and implement necessary actions using pre-trained staff,
pre-developed protocols and standard operating procedures, the existing dedicated
stockpile of antiviral drugs (oseltamivir) and other supplies.
8. Country responsibilities in a containment situation
If a containment effort is undertaken, the country, in consultation and collaboration with
the WHO field team, will be responsible for the following:
Implementation and maintenance of quarantine of all persons and vehicles around
the area of the outbreak. The size of the quarantined area is expected to vary
depending on the specific situation. If the area or size of the population within the
quarantine zone appears to be too large for available staff and supplies, an immediate
consultation will be held between the field team, national authorities, and WHO to
decide whether to terminate containment procedures or whether to proceed.
Distribution and administration of antiviral drugs and monitoring of their use and
effects (including adverse effects) within the quarantine zone. The drugs will be
provided to ill persons for treatment, and to persons without symptoms for
prophylaxis. Doses and duration of treatment will be based upon the most up-to-date
information available at the time. Prophylaxis will continue for at least one week
after the last day of the infectious period of the most recent case. It is anticipated that
quarantine and prophylactic use of antiviral drugs will continue for 4 to 6 weeks and
Implementation and maintenance of all necessary public health measures, such as
isolation of the ill, postponement of large social gatherings, restrictions on
population movement) inside and outside the quarantine area needed to further
reduce opportunities for transmission of the virus.
Monitoring well-being and addressing the physical and mental needs of the
population within the quarantine zone. Examples include the provision of necessary
support (food, water, medical care, shelter, mental and psychological support) and
ensuring the safety of people within the quarantine zone.
The country will be responsible for conducting active surveillance of the area
surrounding the quarantine zone to identify other cases, and for implementing
heightened surveillance in the rest of the country. If the response is thought to have
successfully achieved containment, heightened surveillance throughout the country
should be continued for six months or longer.
Next steps and timeline
Period between 1 February and 6 March 2006
• Initial discussions with regions and countries
• Identification and recruitment of key project staff, including secondments
• Identification of all key issues and scope of work
• Drafting of a detailed core plan, key protocols and standard operating procedures
6 to 10 March 2006
• Global meeting in Geneva to reach agreement on all fundamental concepts and
critical procedures. Prior to this meeting, the WHO working group will have
contacted or visited each relevant member state.
Period between 11 March and 1 April 2006
• Finalization of all details
• Incorporation of comments from countries and other partners
By 1 May
• Development of teaching materials
• Recruitment of a training faculty.
May and onwards
• Start training of staff for the rapid response teams
Sufficient initial funding has been promised to start this project and additional funding is
• A very strong communications component will be needed to explain the project both
as it develops and once it is activated. Although communications were not covered
in this proposal, future drafts will include this component.
• Given that some potential actions such as quarantine and movement restrictions can
raise questions related to individual liberties, ethicists will be brought into the
• At this time, many specific questions exist about some foreseen actions, such as the
size and extent of quarantine and social distancing. As this proposal moves forward,
some modeling groups will be recruited to provide input to help address certain
logistics issues in detail.
• International field teams will be deployed to a country only at the request of that
country. WHO will use the GOARN mechanism to assemble and deploy a team of
responders. Each team will be configured to address the tasks at hand, but a typical
team may consist of a 1) a team leader, 2) epidemiologists (some with clinical
backgrounds), 3) laboratory testing experts; 4) communication specialists (media and
community relations specialists); 5) data base managers; 6) infection control
specialists, 7) a logistician; and 8) an ethicist. If quarantine is instituted, the team
will be split with some members within the quarantine zone and others outside the
• Each country is expected to provide extensive input on how several steps and
activities will be handled within the country on practical issues, such as the
management of antiviral drugs once they arrive within the country. While WHO can
provide guidance on general requirements, each country will be expected to address
details such as import clearance, transportation from airport to outbreak location,
local storage of the antiviral drugs and other stockpiles items, and how use of
antiviral drugs can occur in the absence of national licensing.